Company
You are here » Home » Companies » Company Overview » Bafna Pharmaceuticals Ltd

Bafna Pharmaceuticals Ltd.

BSE: 532989 Sector: Health care
NSE: BAFNAPHARM ISIN Code: INE878I01014
BSE LIVE 15:40 | 23 Jun 24.45 -0.40
(-1.61%)
OPEN

25.00

 HIGH

25.00

 LOW

24.00
NSE 15:46 | 23 Jun 24.30 -0.60
(-2.41%)
OPEN

25.00

 HIGH

25.00

 LOW

24.15
Add to Watchlist  |   Add to Portfolio
OPEN 25.00
PREVIOUS CLOSE 24.85
VOLUME 4586
52-Week high 35.80
52-Week low 23.05
P/E
Mkt Cap.(Rs cr) 46
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 25.00
CLOSE 24.85
VOLUME 4586
52-Week high 35.80
52-Week low 23.05
P/E
Mkt Cap.(Rs cr) 46
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
Filter:

Bafna Pharmaceuticals Ltd. (BAFNAPHARM) - Nine Monthly Result

Particulars ( cr) Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Net Sales/Income From Operations 53.52 59.04 123.80 138.25 120.33
Other Income 1.15 1.22 0.73 1.03 1.43
Total Income 54.67 60.26 124.53 139.28 121.76
Total Expenditure 52.69 53.73 77.68 121.07 101.99
Operating Profit 1.98 6.52 46.85 18.21 19.77
Interest 9.19 9.04 9.79 8.66 7.96
Gross Profit -7.21 -2.52 37.06 9.55 11.81
Depreciation 3.05 2.35 4.88 4.50 5.39
PBT -10.26 -4.87 32.18 5.05 6.42
Tax -0.16 0.47 3.30 1.71 1.88
Net Profit/(Loss) -10.10 -5.34 28.88 3.34 4.54
Minority Interest After NP - - - - -
Net Profit after Minority Interest - - - - -
Exceptional Items 0.00 0.00 -2.41 0.00 0.00
Profit After Exceptional Items -10.10 -5.34 31.29 3.34 4.54
Equity Share Capital 18.66 18.66 18.66 18.66 18.66
Reserves Excluding Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
EPS
Basic EPS -5.41 -2.86 15.48 1.79 2.43
Public Share Holding
No Of Shares (Crores) 0 0 0.12 1.18 1.16
Share Holding (%) 0.00 0.00 63.05 63.50 61.96
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of Shares (Crores) 0 0 0.15 0.15 0.13
- Per. of Shares (as a % of the total sh. of prom. and promoter group) 0.00 0.00 22.19 22.47 18.08
- Per. of Shares (as a % of the total Share Cap. of the company) 0.00 0.00 8.20 8.20 6.88
b) Non-encumbered
- Number of Shares (Crores) 0 0 0.54 0.53 0.58
- Per. of shares (as a % of the total sh. of prom. and promoter group) 0.00 0.00 77.81 77.53 81.92
- Per. of shares (as a % of the total Share Cap. of the company) 0.00 0.00 28.75 28.30 31.16
Note : PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure.
Next

Browse STOCK Companies

Quick Links for Bafna Pharmaceuticals: